Resolian

Resolian is a globally recognized bioanalytical contract research organization (CRO) operating as a premier research laboratory in Malvern, Pennsylvania. Formerly known as Alliance Pharma, Resolian has built a strong reputation within the pharmaceutical and peptide industries by delivering rigorous GxP-compliant bioanalysis and drug metabolism services to clients across the United States and around the world. With deep expertise in clinical trials and drug development workflows, Resolian stands as a trusted partner for researchers, sponsors, and pharmaceutical companies navigating complex bioanalytical challenges from early discovery through late-stage clinical development.

As a full-service research laboratory in Malvern, Resolian offers an extensive portfolio of analytical capabilities designed to support every phase of drug development. Their services span peptide bioanalysis, large and small molecule LC-MS/MS, immunoassay development and validation, flow cytometry, high-resolution mass spectrometry, PCR, and immunogenicity testing. Resolian's research labs also provide specialized support for oligonucleotides and proteins, biomarker analysis, cell and gene therapy modalities, drug conjugate analysis, cannabinoid bioanalysis, and clinical drug-drug interaction studies. Complementing these core offerings are drug metabolism and pharmacokinetics services, nitrosamine analysis, materials characterization, and elemental impurity identification — making Resolian a comprehensive resource for pharmaceutical analytical science.

Resolian occupies a distinguished position in the peptide research and bioanalytical CRO landscape, serving a national client base that includes pharmaceutical companies, biotechnology firms, academic institutions, and clinical research organizations. With inspection-ready standards aligned to FDA, EMA, and MHRA regulatory frameworks, Resolian's research labs are equipped to support sponsors at every stage of the development pipeline. Their major US hub in Malvern, PA serves as a central point of coordination for studies conducted across domestic and international programs, reinforcing their capacity to deliver consistent, high-quality results at scale regardless of geographic scope.

Professionals seeking a trusted research laboratory in Malvern should prioritize partners that demonstrate regulatory readiness, validated methodologies, and broad analytical breadth. Resolian's commitment to GxP principles means that study data generated within their research labs is produced under rigorous quality frameworks designed to meet the demands of regulatory submissions and peer-reviewed research alike. For those working in peptide bioanalysis and drug development, selecting a CRO with demonstrated experience across multiple therapeutic modalities and analytical technologies is essential to ensuring reliable, reproducible, and submission-ready data throughout the development lifecycle.

Industry professionals looking to advance their pharmaceutical research programs are encouraged to connect with Resolian directly to discuss their bioanalytical needs. Whether supporting early-phase discovery, clinical biomarker studies, or complex peptide analysis projects, Resolian brings the scientific expertise, regulatory alignment, and technological infrastructure to serve as a long-term research partner. Reach out to their team in Malvern, PA to learn more about how their nationally recognized research laboratory can support your next project.